We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$204M
2
TSM icon
TSMC
TSM
+$94.9M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$58M
4
IWO icon
iShares Russell 2000 Growth ETF
IWO
+$23M
5
VNQ icon
Vanguard Real Estate ETF
VNQ
+$17.9M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$52.8M
2
AAPL icon
Apple
AAPL
+$32.5M
3
MSFT icon
Microsoft
MSFT
+$16.2M
4
XLE icon
State Street Energy Select Sector SPDR ETF
XLE
+$14.5M
5
DIS icon
Walt Disney
DIS
+$14.2M

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RHP icon
1626
Ryman Hospitality Properties
RHP
$7.69B
$133K ﹤0.01%
1,484
+1,221
+464% +$108K
GATO
1627
DELISTED
Gatos Silver, Inc.
GATO
$133K ﹤0.01%
20,381
+10,665
+110% +$51.3K
GFF icon
1628
Griffon
GFF
$4.84B
$132K ﹤0.01%
4,093
+3,911
+2,149% +$143K
OMCL icon
1629
Omnicell
OMCL
$1.68B
$132K ﹤0.01%
2,253
-4,604
-67% -$254K
RARE icon
1630
Ultragenyx Pharmaceutical
RARE
$2.67B
$132K ﹤0.01%
3,297
-6,614
-67% -$284K
PARAP
1631
DELISTED
Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock
PARAP
$132K ﹤0.01%
+4,396
New +$134K
MAXR
1632
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
$132K ﹤0.01%
2,585
+2,150
+494% +$110K
FLNA
1633
Filana Therapeutics
FLNA
$46.7M
$131K ﹤0.01%
5,433
+3,892
+253% +$108K
OZON
1634
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$131K ﹤0.01%
13,932
– –
ERY icon
1635
Direxion Daily Energy Bear 2X ETF
ERY
$36.7M
$130K ﹤0.01%
4,232
+2,620
+163% +$79K
GLOB icon
1636
Globant
GLOB
$1.69B
$130K ﹤0.01%
793
+637
+408% +$104K
JNPR
1637
DELISTED
Juniper Networks
JNPR
$130K ﹤0.01%
3,776
-3,284
-47% -$104K
SAGE
1638
DELISTED
Sage Therapeutics
SAGE
$130K ﹤0.01%
3,103
+2,234
+257% +$96.1K
GDS icon
1639
GDS Holdings
GDS
$6.56B
$129K ﹤0.01%
6,925
-3,130
-31% -$66.3K
TFX icon
1640
Teleflex
TFX
$5.92B
$129K ﹤0.01%
510
-484
-49% -$117K
ICVX
1641
DELISTED
Icosavax, Inc. Common Stock
ICVX
$129K ﹤0.01%
22,289
+20,910
+1,516% +$181K
APG icon
1642
APi Group
APG
$18.5B
$128K ﹤0.01%
8,523
+6,672
+360% +$95.8K
BUD icon
1643
AB InBev
BUD
$159B
$128K ﹤0.01%
1,920
+1,918
+95,900% +$116K
BXSL icon
1644
Blackstone Secured Lending
BXSL
$5.71B
$128K ﹤0.01%
+5,148
New +$126K
GDDY icon
1645
GoDaddy
GDDY
$11.6B
$128K ﹤0.01%
1,655
+1,604
+3,145% +$124K
PTEN icon
1646
Patterson-UTI
PTEN
$4.2B
$128K ﹤0.01%
10,952
+5,085
+87% +$74.2K
SNY icon
1647
Sanofi
SNY
$105B
$128K ﹤0.01%
2,348
-8,235
-78% -$401K
VCYT icon
1648
Veracyte
VCYT
$3.73B
$128K ﹤0.01%
5,760
+3,863
+204% +$93.4K
NKLA
1649
DELISTED
Nikola Corporation Common Stock
NKLA
$128K ﹤0.01%
3,531
+3,200
+967% +$210K
UNVR
1650
DELISTED
Univar Solutions Inc.
UNVR
$128K ﹤0.01%
3,650
+456
+14% +$15.5K
64 65
66
67 68

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 41.61% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
BOK
Bank of Korea Seoul, South Korea $4.13B AUM
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.